Lumida
/CDTX
⌘K
Cidara Therapeutics Inc

Cidara Therapeutics Inc

CDTX
$221.38USD+0.03%+0.06 today

MARKET CAP

7.0B

P/E (TTM)

FWD P/E

DAY RANGE

$221 – $221

52W RANGE

$15
$221
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$12.1M$49.6M$64.4M$23.3M$1.3M
YoY %-42.3%+310.8%+30.0%-63.9%-94.5%
P / Sales
EV / Sales
Gross Profit, Adj.$12.1M$49.6M$64.4M$23.3M$1.3M
YoY %-42.3%+310.8%+30.0%-63.9%-94.5%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-71.6M$-42.1M$-33.4M$-26.9M$-175.7M
YoY %-72.9%+41.2%+20.7%+19.5%-554.0%
Margin %-593.0%-84.9%-51.8%-115.4%-13779.2%
EV / EBITDA
EBIT$-71.8M$-42.3M$-33.5M$-27.1M$-176.1M
YoY %-72.2%+41.2%+20.7%+19.2%-550.8%
Margin %-595.4%-85.2%-52.0%-116.2%-13811.9%
EV / EBIT
Net Income$-74.9M$-42.5M$-33.6M$-22.9M$-169.8M
YoY %-82.2%+43.3%+20.9%+31.7%-640.6%
Net Margin-620.5%-85.7%-52.1%-98.5%-13319.8%
EPS (GAAP)-$36.00-$16.20-$9.60-$5.25-$26.75
YoY %-31.4%+55.0%+40.7%+45.3%-409.5%